Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High versus low dose intravenous dexamethasone after periacetabular osteotomy
2017-000544-17Phase 4Completed
- Sponsor
- Eske Kvanner Aasvang
- Start
- Feb 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in hip dysplasia (DDH) (2 arms), sponsored by Eske Kvanner Aasvang. Primary endpoint: Proportion of patients with moderate/severe pain in the post anesthesia care unit. Started Feb 2017; status: completed.
02
Drugs
dexamethasone
03
Conditions
hip dysplasia (DDH)
Beyond the preview
Go deeper on 2017-000544-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000544-17.